Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11676685 Artificial intelligence-based quality scoring
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
Illumina
0
Date Filed
March 20, 2020
0
Date of Patent
June 13, 2023
0
Patent Applicant
Illumina
0
Patent Application Number
16826134
0
Patent Citations
US Patent 7566537 Labelled nucleotides
0
US Patent 7592435 Modified nucleosides and nucleotides and uses thereof
0
US Patent 8182993 Methods and processes for calling bases in sequence by incorporation methods
0
US Patent 7115400 Methods of nucleic acid amplification and sequencing
0
US Patent 7211414 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
0
US Patent 7315019 Arrays of optical confinements and uses thereof
0
US Patent 7329492 Methods for real-time single molecule sequence determination
0
US Patent 7427673 Labelled nucleotides
0
US Patent 10023911 Methods and processes for calling bases in sequence by incorporation methods
0
US Patent 10068054 Bioinformatics systems, apparatuses, and methods executed on an integrated circuit processing platform
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11676685
0
Patent Primary Examiner
Khai M Nguyen
0
CPC Code
G06V 10/751
0
G06N 3/04
0
G06N 3/08
0
G06N 3/084
0
G06N 7/005
0
G06N 5/046
0
G06V 10/82
0
G16B 40/00
0
G06K 9/6218
0
G06K 9/6222
0
•••
Find more entities like US Patent 11676685 Artificial intelligence-based quality scoring
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE